SOMEC SPA financials
SOMEC SPA
Country: IT Reporting currency: EUR Latest annual report: 2025-12-31
LEI:
81560001692D0424C949 Financial statements
(EUR, as reported — unscaled; 103 line items across 2 annual periods)
| Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | €370.0M | €382.8M |
| Other income | €4.0M | €5.2M |
| Employee benefits expense | €69.9M | €67.6M |
| Raw materials & consumables used | €131.4M | €161.3M |
| Operating profit (EBIT) | €16.7M | €8.2M |
| Finance costs | €6.6M | €8.3M |
| Profit before tax | €12.1M | €4.6M |
| Income tax expense | €5.0M | €5.1M |
| Profit for the year | €7.1M | -€460.0K |
| — attributable to owners | €4.8M | -€3.3M |
| — attributable to NCI | €2.3M | €2.8M |
| Total comprehensive income | €6.0M | -€640.0K |
| Per share | ||
| Basic EPS | €680.00 | €-480.00 |
| Diluted EPS | €680.00 | €-480.00 |
| Free cash flow / share | €3244.48 | €26284.17 |
| Cash flow statement | ||
| Net cash from operating activities | €37.6M | €27.4M |
| Net cash from investing activities | -€7.2M | -€5.3M |
| Purchase of PP&E (capex) | €3.8M | €2.3M |
| Purchase of intangibles | €168.0K | €168.0K |
| Net cash from financing activities | -€29.2M | -€22.7M |
| Proceeds from borrowings | €897.0K | €0 |
| Repayments of borrowings | €7.1M | €22.6M |
| Lease liability payments | €7.5M | €6.5M |
| Net change in cash | €1.2M | -€513.0K |
| Balance sheet | ||
| Total assets | €280.4M | €315.5M |
| Non-current assets | €93.3M | €92.6M |
| Property, plant & equipment | €18.1M | €18.0M |
| Right-of-use assets | €29.5M | €21.9M |
| Intangible assets & goodwill | €39.8M | €46.0M |
| Current assets | €187.1M | €223.0M |
| Trade & other receivables | €59.7M | €79.7M |
| Cash & equivalents | €47.7M | €47.5M |
| Total equity | €26.0M | €17.7M |
| — attributable to owners | €23.1M | €13.7M |
| Non-controlling interests | €2.8M | €4.0M |
| Non-current liabilities | €80.4M | €51.5M |
| Long-term borrowings | €39.0M | €7.3M |
| Current liabilities | €174.1M | €246.4M |
| Short-term borrowings | €38.6M | €88.9M |
| Trade & other payables | €72.2M | €80.0M |
| Deferred tax liabilities | €5.0M | €6.0M |
| Derived metrics | ||
| Free cash flow | €33.8M | €25.2M |
| Operating margin | 4.5% | 2.1% |
| Net margin | 1.9% | -0.1% |
| Return on equity | 27.3% | -2.6% |
| Cash conversion ratio | 5.31× | -59.66× |
| Capex coverage | 9.82× | 12.17× |
| Other reported items | ||
| Adjustments For Decrease Increase In Trade Account Receivable | €19.0M | -€14.3M |
| Adjustments For Decrease Increase In Trade and Other Receivables | €4.7M | -€2.0M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €12.9M | €14.8M |
| Adjustments For Finance Costs | €4.8M | €6.4M |
| Adjustments For Finance Income | -€574.0K | -€1.6M |
| Adjustments For Impairment Loss Recognised In Profit Or Loss Goodwill | €2.6M | €4.7M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Trade and Other Receivables | €515.0K | €1.3M |
| Adjustments For Income Tax Expense | €5.0M | €5.1M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | -€304.0K | €51.0K |
| Adjustments For Increase Decrease In Trade and Other Payables | -€8.0M | €5.1M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -€60.0K | -€11.0K |
| Adjustments For Provisions | €2.6M | €605.0K |
| Adjustments For Sharebased Payments | -€176.0K | €218.0K |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | -€32.0K | -€3.0K |
| Capital Reserve | -€176.0K | — |
| Cash Flows From Used In Increase Decrease In Current Borrowings | -€12.4M | €7.9M |
| Comprehensive Income Attributable To Noncontrolling Interests | €1.6M | €3.2M |
| Comprehensive Income Attributable To Owners of Parent | €4.4M | -€3.9M |
| Current Tax Assets Current | €5.6M | €5.5M |
| Current Tax Liabilities Current | €4.8M | €6.0M |
| Current Tax Liabilities Noncurrent | €673.0K | €961.0K |
| Deferred Tax Assets | €5.1M | €5.7M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €16.7M | €21.4M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €3.1M | €1.6M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€990.0K | €1.0M |
| Equity and Liabilities | €280.4M | €315.5M |
| Finance Income | €3.6M | €4.5M |
| Income Taxes Paid Refund Classified As Operating Activities | €2.1M | €3.0M |
| Increase Decrease Through Transfers and Other Changes Equity | -€340.0K | — |
| Investments In Associates Accounted For Using Equity Method | €321.0K | €289.0K |
| Issue of Equity | €5.9M | — |
| Issued Capital | €7.3M | €6.9M |
| Liabilities | €254.4M | €297.8M |
| Noncurrent Financial Assets | €529.0K | €646.0K |
| Other Comprehensive Income | -€1.1M | -€180.0K |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | -€192.0K | -€807.0K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -€1.1M | €619.0K |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €205.0K | €8.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€1.3M | -€188.0K |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €205.0K | €8.0K |
| Other Current Financial Assets | €27.7M | €28.1M |
| Other Current Financial Liabilities | €7.6M | €8.5M |
| Other Current Liabilities | €17.2M | €17.4M |
| Other Current Receivables | €12.6M | €17.3M |
| Other Gains Losses | -€1.6M | €237.0K |
| Other Longterm Provisions | €3.4M | €1.1M |
| Other Noncurrent Liabilities | €0 | €292.0K |
| Other Noncurrent Nonfinancial Liabilities | €26.9M | €29.9M |
| Other Operating Income Expense | -€135.4M | -€124.3M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €207.0K | €32.0K |
| Recognised Liabilities Defined Benefit Plan | €5.4M | €5.9M |
| Revenue From Contracts With Customers | €366.0M | €377.6M |
| Settled Liabilities Contingent Liabilities Recognised In Business Combination | -€3.4M | -€2.9M |
| Share of Profit Loss of Associates Accounted For Using Equity Method | €32.0K | €3.0K |
| Share Premium | €23.7M | €18.2M |
| Statutory Reserve | €1.4M | €1.4M |
Methodology
Every line item above is a fact tagged in SOMEC SPA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.